Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bishop

Showing results (901-910 of 1,042) with videos related to

Pageof 105
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantationDaniel H Fowler, Jeanne Odom, Seth M Steinberg, et al.
Blood|August 26, 1998
Allogeneic bone marrow transplantation for low-grade lymphomaK van Besien, K A Sobocinski, P A Rowlings, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 19, 2021
Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disordersSeenae Eum, S Kristian Hill, Ney Alliey-Rodriguez, et al.
Journal of Medicinal Chemistry|January 22, 1998
Structure-activity relationship of 3-substituted N-(pyridinylacetyl)-4- (8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene )- piperidine inhibitors of farnesyl-protein transferase: design and synthesis of in vivo active antitumor compoundsF G Njoroge, B Vibulbhan, D F Rane, et al.
Translational Psychiatry|April 13, 2018
Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controlsRebecca Shafee, Pranav Nanda, Jaya L Padmanabhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2011
Phase I trial of adoptive cell transfer with mixed-profile type-I/type-II allogeneic T cells for metastatic breast cancerNancy M Hardy, Miriam E Mossoba, Seth M Steinberg, et al.
Blood Advances|July 31, 2023
Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphomaMichael Scordo, Jessica R Flynn, Mithat Gonen, et al.
Brain, Behavior, and Immunity|July 28, 2023
Peripheral inflammatory subgroup differences in anterior Default Mode network and multiplex functional network topology are associated with cognition in psychosisPaulo Lizano, Chelsea Kiely, Mite Mijalkov, et al.
Cancer Research Communications|June 4, 2026
CAR T-Cell Kinetics, Persistence and Clinical Outcomes in Adult Patients with Relapsed/Refractory B-Cell ALL Treated with Obecabtagene Autoleucel in the FELIX StudyClaire Roddie, William Day, Meera Raymond, et al.
Bone Marrow Transplantation|March 29, 2011
Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDSS M Luger, O Ringdén, M-J Zhang, et al.
Pageof 105

Showing results (901-910 of 1,042) with videos related to

Sort By:
Pageof 105
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantationDaniel H Fowler, Jeanne Odom, Seth M Steinberg, et al.
Blood|August 26, 1998
Allogeneic bone marrow transplantation for low-grade lymphomaK van Besien, K A Sobocinski, P A Rowlings, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 19, 2021
Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disordersSeenae Eum, S Kristian Hill, Ney Alliey-Rodriguez, et al.
Journal of Medicinal Chemistry|January 22, 1998
Structure-activity relationship of 3-substituted N-(pyridinylacetyl)-4- (8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene )- piperidine inhibitors of farnesyl-protein transferase: design and synthesis of in vivo active antitumor compoundsF G Njoroge, B Vibulbhan, D F Rane, et al.
Translational Psychiatry|April 13, 2018
Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controlsRebecca Shafee, Pranav Nanda, Jaya L Padmanabhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2011
Phase I trial of adoptive cell transfer with mixed-profile type-I/type-II allogeneic T cells for metastatic breast cancerNancy M Hardy, Miriam E Mossoba, Seth M Steinberg, et al.
Blood Advances|July 31, 2023
Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphomaMichael Scordo, Jessica R Flynn, Mithat Gonen, et al.
Brain, Behavior, and Immunity|July 28, 2023
Peripheral inflammatory subgroup differences in anterior Default Mode network and multiplex functional network topology are associated with cognition in psychosisPaulo Lizano, Chelsea Kiely, Mite Mijalkov, et al.
Cancer Research Communications|June 4, 2026
CAR T-Cell Kinetics, Persistence and Clinical Outcomes in Adult Patients with Relapsed/Refractory B-Cell ALL Treated with Obecabtagene Autoleucel in the FELIX StudyClaire Roddie, William Day, Meera Raymond, et al.
Bone Marrow Transplantation|March 29, 2011
Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDSS M Luger, O Ringdén, M-J Zhang, et al.
Pageof 105